Sweeney & Kellner Amend AIM ImmunoTech Filing

TL;DR

Sweeney & Kellner updated their AIM ImmunoTech stake filing. Watch for potential moves.

AI Summary

On September 11, 2024, Paul W. Sweeney and Ted D. Kellner, as part of the Paul W. Sweeney Group, filed an amendment (No. 8) to their Schedule 13D for AIM ImmunoTech Inc. The filing indicates a change in beneficial ownership of the company's common stock. The filing was made with the SEC and pertains to AIM ImmunoTech Inc., a company focused on biological products.

Why It Matters

This amendment signals a potential shift in the control or investment strategy of significant shareholders in AIM ImmunoTech Inc., which could impact the company's stock performance.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant shareholder activity, which can lead to volatility or strategic changes within the company.

Key Numbers

• Amendment No. 8 — Filing Amendment (Indicates this is the eighth update to the original filing)

Key Players & Entities

• Paul W. Sweeney (person) — Filing party and member of the Paul W. Sweeney Group
• Ted D. Kellner (person) — Filing party and member of the Paul W. Sweeney Group
• AIM ImmunoTech Inc. (company) — Subject company of the filing
• 0001193125-24-217325 (filing_id) — Accession number for the SEC filing
• September 11, 2024 (date) — Date of the event requiring the filing

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $5,000 — investment activities for approximately $5,000. Item4. Purpose of the Transaction

Filing Documents

• d848546dsc13da.htm (SC 13D/A) — 60KB
• d848546dex991.htm (EX-99.1) — 42KB
• d848546dex992.htm (EX-99.2) — 9KB
• d848546dex993.htm (EX-99.3) — 3KB
• 0001193125-24-217325.txt ( ) — 116KB

is

Item 2 is supplemented as follows: This Amendment No. 8 is being filed jointly by Mr. Deutsch, Mr. Kellner and Mr. Sweeney. Mr. Sweeneys business address is 758 N. Broadway, Suite 241, Milwaukee, WI 53202. He is a co-founder and principal of PS Capital Partners, a private equity firm with a focus in manufacturing and process-oriented industries. Mr. Sweeney is a U.S. citizen. During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding. During the last five years, none of the Reporting Persons was party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws. Item3. Source and Amount of Funds or Other Consideration

is supplemented as follows

Item 3 is supplemented as follows: Mr. Sweeney acquired the shares of Common Stock he beneficially owns with personal funds in the ordinary course of his investment activities for approximately $5,000. Item4. Purpose of the Transaction

is hereby supplemented as follows

Item 4 is hereby supplemented as follows: On September 11, 2024, Mr. Kellner supplemented (the Supplement) the notice (the Notice) he previously submitted to the Company of his intent to nominate himself, Mr. Deutsch and Mr. Chioini for election to the Companys board of directors at the 2024 annual meeting of stockholders (the Annual Meeting). In the Supplement, Mr. Kellner notified the Company that he also intended to nominate Mr. Sweeney for election to the board of directors at the Annual Meeting. The Reporting Persons are attaching a copy of the Supplement as Exhibit 1 hereto. The Reporting Persons reiterate that it is not their intention, either alone or acting together with any other persons or group of persons, to acquire a control stake in the shares of Common Stock. Beyond the foregoing, the Reporting Persons will review their investments in the Company on a continuing basis and may in the future determine (1) to acquire additional securities of the Company, through open market purchases, private agreements or otherwise, (2) to dispose of all or a portion of the securities of the Company owned by them or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intention with respect to any or all of such matters. In reaching any decision as to its course of action (as well as to the specific elements thereof), the Reporting Persons currently expect that they would take into consideration a variety of factors, including, but not limited to, the following: the actions of the Companys board and management; the Companys business, prospects and financial condition; other developments concerning the Company; other business opportunities available to Company and the Reporting Persons; developments with respect to the businesses of the Reporting Persons; changes in law and government regulations; general economic conditions; and money and stock market cond

is hereby supplemented as follows

Item 6 is hereby supplemented as follows: On September 11, 2024, Mr. Sweeney joined, as an Other Nominee, the agreement, dated September 3, 2024, among the other Reporting Persons and Mr. Chioini. The foregoing summary is qualified by reference in its entirety by the terms and conditions of the joinder to the agreement, a copy of which is attached hereto as Exhibit 2. Item7. Material to be Filed as Exhibits

is hereby supplemented by adding the following exhibits

Item 7 is hereby supplemented by adding the following exhibits: Exhibit No. Name 1. Nomination Notice Supplement, dated September 11, 2024 2. Joinder to Agreement, dated September 11, 2024 3. Joint Filing Agreement

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: September 11, 2024 TODD DEUTSCH By: /s/ Todd Deutsch TED D. KELLNER By: /s/ Ted D. Kellner PAUL W. SWEENEY By: /s/ Paul W. Sweeney

View Full Filing

View this SC 13D/A filing on SEC EDGAR